IL204728A0 - Methods and compounds for treating retinol-related diseases - Google Patents

Methods and compounds for treating retinol-related diseases

Info

Publication number
IL204728A0
IL204728A0 IL204728A IL20472810A IL204728A0 IL 204728 A0 IL204728 A0 IL 204728A0 IL 204728 A IL204728 A IL 204728A IL 20472810 A IL20472810 A IL 20472810A IL 204728 A0 IL204728 A0 IL 204728A0
Authority
IL
Israel
Prior art keywords
compounds
methods
related diseases
retinol
treating
Prior art date
Application number
IL204728A
Original Assignee
Revision Therapeutics Inc
Sirion Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Revision Therapeutics Inc, Sirion Therapeutics Inc filed Critical Revision Therapeutics Inc
Publication of IL204728A0 publication Critical patent/IL204728A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
IL204728A 2007-09-27 2010-03-25 Methods and compounds for treating retinol-related diseases IL204728A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US97576507P 2007-09-27 2007-09-27
US98132207P 2007-10-19 2007-10-19
PCT/US2008/076499 WO2009042444A2 (en) 2007-09-27 2008-09-16 Methods and compounds for treating retinol-related diseases

Publications (1)

Publication Number Publication Date
IL204728A0 true IL204728A0 (en) 2010-11-30

Family

ID=40512081

Family Applications (1)

Application Number Title Priority Date Filing Date
IL204728A IL204728A0 (en) 2007-09-27 2010-03-25 Methods and compounds for treating retinol-related diseases

Country Status (8)

Country Link
EP (1) EP2205234A4 (en)
JP (1) JP2010540541A (en)
KR (1) KR20100097098A (en)
CN (1) CN101873852A (en)
AU (1) AU2008305303A1 (en)
CA (1) CA2699773A1 (en)
IL (1) IL204728A0 (en)
WO (1) WO2009042444A2 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009051244A1 (en) * 2007-10-18 2009-04-23 Takeda Pharmaceutical Company Limited Heterocyclic compound
SG175718A1 (en) * 2009-04-16 2011-12-29 Takeda Pharmaceutical Derivatives of n-acyl-n'-phenylpiperazine useful (inter alia) for the prophylaxis or treatment of diabetes
US8980924B2 (en) 2010-11-24 2015-03-17 The Trustees Of Columbia University In The City Of New York Non-retinoid RBP4 antagonist for treatment of age-related macular degeneration and stargardt disease
RU2013129999A (en) * 2010-12-02 2015-01-10 Дайити Санкио Компани, Лимитед MODIFIED SINGLE-CHAIN POLYNUCLEOTIDE
US9333202B2 (en) 2012-05-01 2016-05-10 The Trustees Of Columbia University In The City Of New York Non-retinoid antagonists for treatment of age-related macular degeneration and stargardt disease
WO2014151936A1 (en) 2013-03-14 2014-09-25 The Trustees Of Columbia University In The City Of New York Octahydropyrrolopyrroles, their preparation and use
WO2014151959A1 (en) 2013-03-14 2014-09-25 The Trustees Of Columbia University In The City Of New York N-alkyl-2-phenoxyethanamines, their preparation and use
DK2968304T3 (en) 2013-03-14 2019-01-28 Univ Columbia 4-PHENYLPIPERIDINES, THEIR PREPARATION AND USE.
WO2014152018A1 (en) 2013-03-14 2014-09-25 The Trustees Of Columbia University In The City Of New York Octahydrocyclopentapyrroles, their preparation and use
CN111393434B (en) 2014-04-30 2022-11-04 哥伦比亚大学董事会 Substituted 4-phenylpiperidines, their preparation and use
WO2016063934A1 (en) * 2014-10-24 2016-04-28 武田薬品工業株式会社 Heterocyclic compound
MA53568A (en) 2014-10-24 2022-02-23 Takeda Pharmaceuticals Co DRUGS FOR THE TREATMENT OF OPHTHALMIC DISEASES

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2526534A (en) * 1948-07-03 1950-10-17 Dow Chemical Co Di-(aryloxy)-methanes
US4255152A (en) * 1978-09-05 1981-03-10 Ciba-Geigy Corporation Process for the dyeing of hydrophobic fibres
JPS577480A (en) * 1980-06-16 1982-01-14 Sankyo Co Ltd 4-alkoxy-6-phenoxymethyl-2-pyrone derivative
US7510710B2 (en) * 2004-01-08 2009-03-31 The Regents Of The University Of Colorado Compositions of UCP inhibitors, Fas antibody, a fatty acid metabolism inhibitor and/or a glucose metabolism inhibitor
US20090155903A1 (en) * 2004-03-19 2009-06-18 Myriad Genetics, Incorporated Pharmaceutical composition and method
WO2005116010A1 (en) * 2004-05-26 2005-12-08 Merck Frosst Canada Ltd. Ep4 receptor agonist, compositions and methods thereof

Also Published As

Publication number Publication date
EP2205234A2 (en) 2010-07-14
JP2010540541A (en) 2010-12-24
EP2205234A4 (en) 2010-12-22
WO2009042444A2 (en) 2009-04-02
WO2009042444A3 (en) 2009-05-14
CN101873852A (en) 2010-10-27
AU2008305303A1 (en) 2009-04-02
CA2699773A1 (en) 2009-04-02
KR20100097098A (en) 2010-09-02

Similar Documents

Publication Publication Date Title
IL257418A (en) Methods for treating dependence
EP2176283A4 (en) Methods and compositions for treating brain diseases
HK1156631A1 (en) Novel compounds and methods for therapy
EP2252148A4 (en) Methods for treating bowel diseases
IL204728A0 (en) Methods and compounds for treating retinol-related diseases
EP2170311A4 (en) Compounds and methods for treating or preventing autoimmune diseases
IL200862A0 (en) 3-imidazolyl-indoles for the treatment of proliferative diseases
IL209216A0 (en) Methods for preventing and treating neurodegenerative diseases
HK1162366A1 (en) Devices and methods for treating and or preventing diseases
EP2300011A4 (en) Therapeutic methods and compounds
EP2341936A4 (en) METHODS FOR TREATING OR PREVENTING IL-1ß RELATED DISEASES
HK1245679A1 (en) Methods and compositions for treating dermatological diseases and conditions
EP2205072A4 (en) Methods for treating a variety of diseases and conditions, and compounds useful therefor
EP2124547A4 (en) Cancer treatment method
HK1139856A1 (en) Methods for treating acute pain
EP2144888A4 (en) Methods for treating cancer
GB0718684D0 (en) Treatment method
EP2039392A4 (en) Device for physiotherapeutically treating diseases of different ethiologies
ZA200808076B (en) Methods for preventing and treating amyloidogenic diseases
EP2068911A4 (en) Methods for treating cancer
EP2164494A4 (en) Methods of treatment
IL226363A0 (en) Compounds and methods for the treatment of cancer
GB201008346D0 (en) Methods and compounds for phototransfer
HK1209754A1 (en) Compounds and methods for the treatment of cancer
EP2203432A4 (en) Method of treatment